Controlling shareholder of Hunan Fangsheng Pharmaceutical (603998.SH) increase their holdings by 10,000 shares, planning to increase their holdings to no less than 2 million yuan.

Hunan Fangsheng Pharmaceutical (603998.SH) announced that one of the company's controlling shareholders, Zhang Qinghua, and a concerted action person, Zhang Zuyong, increased their holdings by 10,000 shares of the company on February 11, 2025 through the Shanghai Stock Exchange trading system in a centralized bidding manner, accounting for 0.0023% of the total shares of the company. The total amount of the increase was 94,800 yuan. Zhang Zuyong plans to increase his holdings of the company's shares through the Shanghai Stock Exchange trading system in a centralized bidding manner from February 11, 2025 until August 10, 2025. The total planned increase amount shall not be less than 2 million yuan, and not exceed 4 million yuan (including the aforementioned amount already increased).